Clarity Pharmaceuticals
Health Care · Biotechnology
Data updated Nov 22, 2026Full reportReport a mistake
Lately:4 news stories in 90 daysFollow changes →
Facts
as of Nov 22, 2026Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.
- Employees
- 11-50estimated range
- Official records
- Wikidata Q140045430
- Website
- claritypharmaceuticals.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
Products
Products →Clarity Pharmaceuticals has 11 clinical trials on record, 3 under way.
Clinical trials
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate …
phase 3 · under way · 220 participants · Prostate Cancer; Prostate Cancer Patients With Detectable PSA Following Prostat…
May 2025
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Pro…
phase 3 · under way · 383 participants · Prostate Cancer; Prostatic Neoplasms
Dec 2023
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing …
phase 2 · stopped or withdrawn · 4 participants · Prostatic Neoplasms; Castration-Resistant
Jun 2023
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Risk
Full record →Clarity Pharmaceuticals: 24 research papers in five years.
No match
None
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Newsroom
Newsonclive
Oct 17
Press releasePRNewswire
Oct 8
Sources: the outlets named on each headline, each story once
